To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the implications of the cost differential of the AstraZeneca vaccine for the UK and Uganda in achieving the Prime Minister's aim of making sure everybody gets the vaccines that they need so that the whole world can come through this pandemic together.
The UK is taking a strong global leadership role in collaborating with other countries in the development and distribution of a successful vaccine and we are encouraging other high-income countries to do the same. The UK is one of the largest bilateral donors to the COVAX Advance Market Commitment (AMC), which will give lower and middle-income countries equitable access to vaccines that are developed. The UK has committed £548 million to the COVAX AMC.
Pricing of COVID-19 vaccines between pharmaceutical companies and other countries is a matter for those parties involved.